Fundraising Fox
Biorelate
Manchester, GB · 3 known investors
Find your way into Biorelate
Sign up to find every way you can get introduced to Biorelate
- Your email: who you already know at Biorelate, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Biorelate team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Biorelate provides AI-led biomedical data curation for the biopharma industry, extracting cause-and-effect evidence from scientific literature to support drug discovery. It serves biotechs, pharmaceutical companies, data scientists, and computational biologists through its Galactic AI platform.
Founders & leadership
Investors · 3
Funding
SEC filings, press & company announcements- Undisclosed amountSeries ANov 2022Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Companies House · registry record
View on Companies House ↗- Registered name
- BIORELATE LIMITED
- Company number
- 09087514
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 16 Jun 2014
- Registered office
- Unit 9 Williams House Lloyd Street North, Manchester Science Park, Manchester, M15 6SE
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Mar 2025 · next due 31 Dec 2026
- Confirmation statement
- last made up to 21 Oct 2025 · next due 4 Nov 2026
Current officers · 4
- Bronwyn Murray — secretary, appointed 25 Jun 2024
- Gavin Bell — director, appointed 28 Nov 2022
- Jason Charles Foster — director, appointed 21 Aug 2026
- Daniel Jamieson — director, appointed 16 Jun 2014
Source: Companies House public register · retrieved 6 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Biorelate do?
- Biorelate provides AI-led biomedical data curation for the biopharma industry, extracting cause-and-effect evidence from scientific literature to support drug discovery. It serves biotechs, pharmaceutical companies, data scientists, and computational biologists through its Galactic AI platform.
- Who founded Biorelate?
- Biorelate was founded by Daniel Jamieson.
- Who are Biorelate's investors?
- Biorelate's investors include Catapult Ventures, Maven Capital Partners, YFM Equity Partners.
- Where is Biorelate headquartered?
- Biorelate is headquartered in Manchester, GB.